Skip to main content
Caplight Logo









InvenireX

InvenireX

Private
Newcastle upon TyneHealthcare & Life Scienceshttps://www.invenirex.co.uk/

Last Round

Seed

Nov 18, 2025

Total Funding Raised

$3.27M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

InvenireX is a biotechnology company that develops an ultra-sensitive, real-time nucleic acid detection platform powered by DNA nanotechnology and artificial intelligence for use in molecular diagnostics and life sciences research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

nucleic acid detectionmolecular diagnosticsDNA nanotechnologyamplification-free detectionPCR alternativeAI-powered diagnosticsliquid biopsyearly disease detectionbenchtop instrumentlife sciences research toolsenzyme-free detectionmicrofluidic chipsreal-time quantificationinfectious disease diagnosticsvaccine quality control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InvenireX Comparables

Compare InvenireX with similar companies based on industry and business-model similarity.

InvenireX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QuantuMDx
71%
AltraTech Limited
68%
Oxford Nanopore Technologies
67%

InvenireX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 18, 2025
SeedMar 18, 2024

Key People

Founding team and executive leadership

Dan Todd

Founder & CEO

Founding Team

InvenireX Investors

Notable investors and investment history

InvenireX investors
InvestorRounds
Innovate UKSeed
XTX VenturesSeed
DSW VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 18, 2025

    $2.6M raised led by DSW Ventures.

  • Nov 12, 2025

    Grew 100% QoQ from 5 to 10 employees.

InvenireX Filings

Explore SEC and related filing metadata, where available.

InvenireX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InvenireX's valuation, stock price, and market status.

Is InvenireX a public or private company?

InvenireX is a private company.

What is the current stock price of InvenireX?

InvenireX is a private company with no public stock price. No recent secondary market data is available.

How much is InvenireX worth (valuation)?

Valuation information for InvenireX is not publicly available.

Can I buy InvenireX stock?

InvenireX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was InvenireX's last funding round?

InvenireX's most recent funding round was Seed on November 18, 2025.

Who are the main investors in InvenireX?

Key investors in InvenireX include DSW Ventures.

Will InvenireX IPO soon?

No public IPO plans have been announced for InvenireX.

How can I track InvenireX secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InvenireX's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewcastle upon Tyne
Employee Range8
Year Founded2021
Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?